SB
LABU icon

Simmons Bank’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Simmons Bank’s Portfolio LABU Stock Details LABU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$349K Buy
+1,195
New +$229K 0.02% 311

Other funds holding LABU

Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
MIG
McGuire Investment Group Wakefield, Rhode Island $1.14B AUM 79.59% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
Walleye Trading
Walleye Trading New York $87.6B AUM 68.17% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
HHGA
Halbert Hargrove Global Advisors Long Beach, California $2.31B AUM 21.64% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
RQS
Ramsey Quantitative Systems Louisville, Kentucky $112M AUM 16.38% 1-Year Est. Return
PS
PayPay Securities Tokyo, Japan $4.1M AUM 0.16% 1-Year Est. Return
CPG
Cornerstone Planning Group Fairfield, New Jersey $794M AUM 22.68% 1-Year Est. Return

Simmons Bank's LABU Position: Q2 2026 in Review

Simmons Bank opened a new position in Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q2 2026: 1,195 shares worth $349K. The stake represents 0.02% of the portfolio and ranks #311 among its holdings.

14 funds tracked by Wall St. Rank hold LABU as of Q2 2026.

  • Simmons Bank held 1,195 shares of Direxion Daily S&P Biotech Bull 3X ETF worth $349K as of Q2 2026.
  • Direxion Daily S&P Biotech Bull 3X ETF was a new Simmons Bank position in Q2 2026.
  • Direxion Daily S&P Biotech Bull 3X ETF made up 0.02% of Simmons Bank's portfolio in Q2 2026, its #311 holding.
  • 14 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q2 2026.

Based on Simmons Bank's 13F filing for Q2 2026, filed 31 Jul 2026.